10.6084/m9.figshare.8186843.v1 Marija V. Anđelković Marija V. Anđelković Slobodan M. Janković Slobodan M. Janković Marina J. Kostić Marina J. Kostić Radica S. Živković Zarić Radica S. Živković Zarić Valentina D. Opančina Valentina D. Opančina Miloš Ž. Živić Miloš Ž. Živić Marko J. Milosavljević Marko J. Milosavljević Ana V. Pejčić Ana V. Pejčić Antimicrobial treatment of <i>Stenotrophomonas maltophilia</i> invasive infections: Systematic review Taylor & Francis Group 2019 Stenotrophomonas maltophilia invasive infections systematic review antibiotic treatment 2019-05-25 07:27:08 Dataset https://tandf.figshare.com/articles/dataset/Antimicrobial_treatment_of_i_Stenotrophomonas_maltophilia_i_invasive_infections_Systematic_review/8186843 <p><i>Stenotrophomonas maltophilia</i> can cause serious infections in immunocompromised patients. The aim of this systematic review was to establish what invasive infections in humans are caused by <i>S. maltophilia</i> and to evaluate the optimal choice of antibiotics for their treatment. MEDLINE, EBSCO, SCOPUS, SCINDEKS and GOOGLE SCHOLAR were systematically searched for clinical trials, observational studies, case reports or case series describing invasive infections with <i>S. maltophilia</i> in patients of any age. <i>S. maltophilia</i> may cause invasive infections of various tissues in hospitalized patients. In the great majority of cases it was susceptible to co-trimoxazole, levofloxacin and ceftazidime. In about three fourths of the cases, the treatment was successful, while less than 20% of the patients died. <i>S. maltophilia</i> is increasingly associated with serious invasive infections in hospitalized patients and due to growing trend of resistance to almost all antibiotics requires a careful approach to patients who is harboring this bacterium.</p>